Last update 18 Aug 2025

Raguneprocel

Overview

Basic Info

Drug Type
Induced pluripotent stem cells (iPSC)
Synonyms
CT1-DAP001, DSP 1083, DSP-1083
+ [1]
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System DiseasesEndocrinology and Metabolic Disease
Active Indication
Parkinson Disease
Inactive Indication-
Originator Organization
Sumitomo Pharma America, Inc.Sumitomo Pharma America, Inc.
Active Organization
Sumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.Sumitomo Pharma America, Inc.Sumitomo Pharma America, Inc.
Inactive Organization-
License Organization-
Drug Highest PhaseNDA/BLA
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Raguneprocel
NCT06753331
/ RecruitingPhase 1
A Multicenter, Sham-controlled, Randomized Study to Evaluate the Safety, Tolerability, and Clinical Responses Following Stereotactic Intracranial Implantation of DSP-1083 Into Subjects With Parkinson's Disease
NCT06482268
/ RecruitingPhase 1IIT
An Investigator-initiated Clinical Trial of Safety and Efficacy of Transplantation of Human Induced Pluripotent Stem Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)
100 Clinical Results associated with Raguneprocel
Login to view more data
100 Translational Medicine associated with Raguneprocel
Login to view more data
100 Patents (Medical) associated with Raguneprocel
Login to view more data
100 Deals associated with Raguneprocel
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Parkinson DiseaseNDA/BLA
Japan
Sumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.
05 Aug 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free